A carregar...
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
AIMS: SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. METHODS: Virus binds to the cell surface receptor ACE2; indeed, recen...
Na minha lista:
| Publicado no: | Acta Diabetol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Milan
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275134/ https://ncbi.nlm.nih.gov/pubmed/32506195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-020-01539-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|